BVT Aktienanleihe AMD 31.12.2024/ DE000VM3PPR2 /
6/21/2024 2:07:47 PM | Chg.-0.090 | Bid2:07:47 PM | Ask2:07:47 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
102.040EUR | -0.09% | 102.040 Bid Size: 50,000 |
102.140 Ask Size: 50,000 |
Advanced Micro Devic... | 80.00 USD | 12/31/2024 | Call |
GlobeNewswire
6/19
AMD to Power AI-Based Smart Parking Solution for Sun Singapore, the Country’s Largest Provider of Sm...
GlobeNewswire
6/18
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire
6/17
D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
GlobeNewswire
6/14
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire
6/13
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire
6/13
Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire
6/12
Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire
6/12
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire
6/12
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire
6/11
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire
6/10
SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire
6/8
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...